DGX vs. ISRG: Quest Diagnostics vs. Intuitive Surgical Stock Comparison

Company Profile

Quest Diagnostics (DGX) and Intuitive Surgical (ISRG) both fall under the Health Care Equipment & Services industry group, but DGX is classified in Health Care Providers & Services while ISRG is classified in Health Care Equipment & Supplies.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Intuitive Surgical (ISRG) has an aggressive beta of 1.41, indicating higher sensitivity to broad-market moves, while Quest Diagnostics (DGX) is defensive at 0.54 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Both Quest Diagnostics (DGX) at 15.32% and Intuitive Surgical (ISRG) at 17.93% sit in the top peer quartile for ROE, suggesting each generates more profit from shareholders’ equity than typical industry peers.

For every dollar of sales, both Quest Diagnostics (DGX) at 9.54% and Intuitive Surgical (ISRG) at 25.54% retain more as net profit than most peers, landing in the top net margin quartile of their industries.

Both Quest Diagnostics (DGX) at 15.63% and Intuitive Surgical (ISRG) at 33.29% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.

Profitability Metrics

Growth

Intuitive Surgical (ISRG) at 20.51% sits in the top revenue growth quartile, while Quest Diagnostics (DGX) at 11.78% is closer to the peer norm — faster top-line expansion for ISRG.

Both Quest Diagnostics (DGX) at 13.78% and Intuitive Surgical (ISRG) at 22.59% land near their industries' usual EPS growth ranges, so bottom-line momentum looks broadly in line with peers on both sides.

Growth Metrics

Financial Strength

Both Quest Diagnostics (DGX) at 1.70 and Intuitive Surgical (ISRG) at 3.33 carry current ratio within their industries’ typical mid-ranges, suggesting balanced short-term liquidity relative to peers.

Only one side’s leverage can be read here: Quest Diagnostics (DGX) carries debt-to-equity ratio of 0.80 against its industry range, while Intuitive Surgical (ISRG) reports no figure this period.

Financial Strength Metrics

Dividends

Intuitive Surgical (ISRG) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Quest Diagnostics (DGX) reports a yield of 1.33%, ranking against industry peers normally.

Intuitive Surgical (ISRG) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Quest Diagnostics (DGX) reports a payout of 25.10%, ranking against industry peers normally.

Dividend Metrics

Valuation

Quest Diagnostics (DGX) at 25.46 is near its industry’s usual P/E ratio, while Intuitive Surgical (ISRG) at 54.75 sits in the richer quartile — ISRG needs stronger growth or earnings quality to justify the premium.

Quest Diagnostics (DGX) at 2.38 prices around its industry’s typical P/S ratio, while Intuitive Surgical (ISRG) at 13.82 clears its benchmark range — ISRG looks notably rich on sales.

Quest Diagnostics (DGX) at 3.68 is valued about in line with its industry on P/B ratio, while Intuitive Surgical (ISRG) at 9.82 carries an above-peer premium to book — ISRG is pricier on assets.

Valuation Metrics